Nov 10, 2021 | biomarkers, precision medicine |
B-lymphocyte antigen CD19 or CD19 [Cluster of Differentiation 19] is a protein that is encoding by the CD19 gene and is expressed in B-cells [B-cells are a type of white blood cell]. because CD19 is expressed on all B-cells [80% of ALL, 88% of B-cell lymphomas and...
Nov 10, 2021 | biomarkers, precision medicine |
BRCA1 [BReast CAncer gene 1] and BRCA2 [BReast CAncer gene 2] are genes that produce proteins that help repair damaged DNA. everyone has two copies of each of these genes—inherited from each parent and despite what their names suggest, BRCA1 and BRCA2 do not cause...
Nov 8, 2021 | biomarkers, precision medicine |
biomarker testing has revolutionized cancer treatment for many tumour types. biomarkers is a term used to describe many different potential markers of cancer development and progression. these markers can come in many forms – proteins, biochemicals, DNA and...
Nov 3, 2021 | biomarkers, health policy, innovation, oncology, precision medicine |
because we know that cancer can be highly variable from one person to the other, based on the changes at the molecular level, each patient, even those with the same diagnosis, have a unique set of changes that influence how a person will respond to therapy, or how...
Nov 2, 2021 | biomarkers, precision medicine |
since chemotherapy was introduced in the 1940, cancers have been treated according to the organ or tissue where the cancer has originated [eg. lung or breast cancer]. in precision medicine, sometimes referred to as precision oncology when dealing specifically with...
